Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2003 R33 PAR-01-104 LAM, KIT S UNIVERSITY OF CALIFORNIA DAVIS SMALL MOLECULE MICROARRAYS FOR INTRACELLULAR PROTEINS Complete
2016 R33 RFA-CA-15-005 SOKER, SHAY WAKE FOREST UNIVERSITY HEALTH SCIENCES BIOENGINEERED LUNG TUMOR ORGANOIDS FOR DEVELOPMENT OF PERSONALIZED MEDICINE Complete
2000 R33 PAR-99-100 CONTAG, CHRISTOPHER H STANFORD UNIVERSITY VISIBLE ANIMAL MODELS OF NEOPLASTIC DISEASE Complete
2018 R33 RFA-CA-17-011 CHENG, JI-XIN BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level Active
2022 R33 CA21-004 ADEY, ANDREW OREGON HEALTH & SCIENCE UNIVERSITY Accessible high-throughput single-cell genome sequencing Active
2004 R33 PAR-01-106 ZANGAR, RICHARD C BATTELLE PACIFIC NORTHWEST LABORATORIES PROTEOMIC IDENTIFICATION OF NAF BIOMARKERS Complete
2004 R33 PAR-01-106 SINGER, ROBERT H ALBERT EINSTEIN COL OF MED YESHIVA UNIV FISH AND CHIPS: SINGLE CELL EXPRESSION OF CANCER GENES Complete
2007 R33 RFA-CA-07-001 MILOSAVLJEVIC, ALEKSANDAR BAYLOR COLLEGE OF MEDICINE MULTIPLEXED METHODS FOR THE STUDY OF CHROMOSOMAL ABERRATIONS IN CANCER Complete
2017 R33 RFA-CA-16-002 KELLEY, SHANA O UNIVERSITY OF TORONTO Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis Complete
2021 R33 RFA-CA-20-018 SEELIG, GEORG UNIVERSITY OF WASHINGTON Joint receptor and protein expression immunophenotyping through split-pool barcoding Active
2003 R33 PAR-01-106 FURGE, KYLE A VAN ANDEL RESEARCH INSTITUTE COMPARATIVE GENOMIC ANALYSIS OF MICROARRAY DATA Complete
2000 R33 PAR-99-102 POOLA, INDIRA NONE HOWARD UNIVERSITY MOLECULAR ASSAY FOR ESTROGEN RECEPTORS IN BREAST TUMORS Complete
2018 R33 RFA-CA-17-011 CIMA, MICHAEL J MASSACHUSETTS INSTITUTE OF TECHNOLOGY Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors NCE
2022 R33 CA21-004 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Optogenetic Control of Tumor Initiation and Tumor Progression in vivo Active
2007 R33 RFA-CA-07-001 ROTHSTEIN, RODNEY J. COLUMBIA UNIVERSITY HEALTH SCIENCES USING SYNTHETIC DOSAGE LETHALITY TO SCREEN FOR NOVEL ANTI-TUMOR TARGETS Complete
2017 R33 RFA-CA-16-002 WANG, YINGXIAO UNIVERSITY OF CALIFORNIA, SAN DIEGO Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells Complete
2021 R33 RFA-CA-20-018 GREENBERG, JOEL DUKE UNIVERSITY Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens Active
2001 R33 PAR-98-067 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS Complete
2003 R33 PAR-01-106 COLLINS, COLIN C UNIVERSITY OF CALIFORNIA SAN FRANCISCO DEVELOPMENT OF ESP: STRUCTURAL & FUNCTIONAL ONCOGENOMICS Complete
2013 R33 RFA-CA-12-003 JI, HANLEE P STANFORD UNIVERSITY OLIGONUCLEOTIDE-SELECTIVE SEQUENCING FOR INTEGRATED AND RAPID CANCER GENOME ANALY Complete
2018 R33 RFA-CA-17-011 JIANG, NING UNIVERSITY OF TEXAS, AUSTIN An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer Active
2010 R21 RFA-CA-09-008 SZMACINSKI, HENRYK UNIVERSITY OF MARYLAND BALTIMORE METHOD FOR DETECTION OF SECRETED PROTEINS IN SINGLE CELL ASSAYS Complete
2007 R21 RFA-CA-07-001 HUANG, FAQING UNIVERSITY OF SOUTHERN MISSISSIPPI FOLATE RECEPTOR-MEDIATED SIRNA DELIVERY TO CANCER CELLS Complete
2009 R21 RFA-CA-08-009 FOWLER, CAROL B AMERICAN REGISTRY OF PATHOLOGY, INC. RECOVERY OF PROTEINS FROM FORMALIN-FIXED TISSUES UNDER HIGH HYDROSTATIC PRESSURE Complete
2020 R21 RFA-CA-19-019 ALEXANDRAKIS, GEORGIOS UNIVERSITY OF TEXAS ARLINGTON Nanotechnology Enabled Selection Of MHC-peptide Ligands To Personalize Cancer Therapy Active
2006 R21 RFA-CA-06-003 FRANKENBURG, SHOSHANA HADASSAH-HEBREW UNIVERSITY MEDICAL CTR TARGETED ANTIGEN DELIVERY FOR CANCER IMMUNOTHERAPY Complete
2012 R21 RFA-CA-12-002 DAVALOS, RAFAEL VIDAL VIRGINIA POLYTECHNIC INST AND ST UNIV ISOLATION OF TUMOR INITIATING CELLS (TICS) USING CONTACTLESS DIELECTROPHORESIS Complete
2019 R21 RFA-CA-18-002 O'NEILL, RACHEL UNIVERSITY OF CONNECTICUT STORRS Development and Utilization of Splice-specific Antibodies Active
2000 R21 PAR-99-100 SUTHERLAND, JOHN CLARK BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB DNA DAMAGE QUANTITATION BY SINGLE MOLECULE LASER SIZING Complete
2002 R21 PAR-99-100 SWANSON, BASIL I. UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB OPTICAL BIOSENSOR FOR THE EARLY DETECTION OF CANCER Complete
2005 R21 RFA-CA-05-003 HYSLOP, TERRY THOMAS JEFFERSON UNIVERSITY NONLINEAR MODELS OF MRNA EXPRESSION IN CANCER BY RT-PCR Complete
2008 R21 RFA-CA-07-035 NELSON, EDWARD L UNIVERSITY OF CALIFORNIA-IRVINE APPLICATION OF A NOVEL NANOTECHNOLOGY FOR MOLECULAR PROFILING OF TUMOR CELLULAR E Complete
2011 R21 RFA-CA-10-005 MCDONALD, JOHN F GEORGIA INSTITUTE OF TECHNOLOGY USE OF NANOGELS TO TARGET DELIVERY OF SIRNA TO CANCER CELLS IN MICE Complete
2015 R21 RFA-CA-14-003 VO-DINH, TUAN DUKE UNIVERSITY NANOPLASMONICS-BASED MOLECULAR ANALYSIS TOOL FOR MOLECULAR BIOMARKERS OF CANCER Complete
2010 R21 RFA-CA-09-008 LIU, GUODONG NORTH DAKOTA STATE UNIVERSITY DEVELOPMENT OF A HAND-HELD CANCER BIOMARKER MONITOR Complete
2007 R21 RFA-CA-07-001 DING, ZHIYONG UT MD ANDERSON CANCER CTR EFFECTIVE MAMMALIAN TWO HYBRID SCREENING APPROACH Complete
2006 R21 RFA-CA-06-003 MEYER, TOBIAS STANFORD UNIVERSITY DISSECTION OF THE MODULAR STRUCTURE OF CANCER SIGNALING SYSTEMS Complete
2009 R21 RFA-CA-08-006 LESSNICK, STEPHEN L. UNIVERSITY OF UTAH ANTIBODY-BASED DETECTION OF TRANSLOCATIONS IN PEDIATRIC CANCER Complete
2012 R21 RFA-CA-12-002 TAO, NONGJIAN ARIZONA STATE UNIVERSITY-TEMPE CAMPUS CHARGE SENSITIVE OPTICAL DETECTION FOR HIGH THROUGHPUT STUDY OF SMALL MOLECULES Complete
2016 R21 RFA-CA-15-002 BURGETT, ANTHONY WG UNIVERSITY OF OKLAHOMA NORMAN MASS SPECTROMETRY DETECTION OF DRUGS IN SINGLE BLADDER CANCER CELLS FROM PATIENTS Complete
2019 R21 RFA-CA-18-002 MONTAGNA, CRISTINA ALBERT EINSTEIN COLLEGE OF MEDICINE Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions Active
2000 R21 PAR-99-100 MAJUMDAR, ARUNAVA UNIVERSITY OF CALIFORNIA BERKELEY OPTOMECHANICAL CHIPS FOR MOLECULAR PROFILING OF CANCER Complete
2002 R21 PAR-99-102 CHODOSH, LEWIS A UNIVERSITY OF PENNSYLVANIA TEMPORAL ANALYSIS OF MAMMARY CARCINOGENESIS Complete
2005 R21 RFA-CA-05-003 GREEN, ROLAND D NIMBLEGEN SYSTEMS, INC. MAPPING REGULATORY PATHWAYS IN CANCERS Complete
2008 R21 RFA-CA-07-035 KEELY, PATRICIA J UNIVERSITY OF WISCONSIN-MADISON USING NEW OPTICAL TECHNIQUES TO STUDY CELL SIGNALING IN 3D MATRICES Complete
2011 R21 RFA-CA-10-005 ZEICHNER, STEVEN L CHILDREN'S RESEARCH INSTITUTE DEVELOPMENT OF AN IN VIVO SCREENING TECHNOLOGY FOR CANCER VACCINE IMMUNOGENS Complete
2015 R21 RFA-CA-14-005 MITRAGOTRI, SAMIR S UNIVERSITY OF CALIFORNIA SANTA BARBARA ASSESSING THE RISK OF UV-INDUCED SKIN CANCER VIA NON-INVASIVE EPIDERMAL SAMPLING Complete
2022 R21 CA21-003 LIN, QIAO COLUMBIA UNIV NEW YORK MORNINGSIDE A Practical Approach to Tumor-Specific Aptamers for B-Cell Hematologic Malignancies Active
2010 R21 RFA-CA-09-008 SOUSA, RUI J. UNIVERSITY OF TEXAS HLTH SCIENCE CENTER DEVELOPMENT OF IMAGING REAGENTS TO MONITOR GTP LEVELS AND GTP/GDP RATIOS IN VIVO Complete
2007 R21 RFA-CA-07-001 BIEBERICH, CHARLES J. UNIVERSITY OF MARYLAND BALT CO CAMPUS AN INNOVATIVE APPROACH FOR PROFILING PROTEIN KINASE SUBSTRATES Complete

Pages